REACH: What Did We Learn and What’s Next?
This seminar discussed experiences and best practices in consortium management and REACH registration and addressed the challenges associated with the next phases of REACH, including the use of science in regulatory decisionmaking.
Once the first wave of registration dossiers were submitted, it was an opportune time to reflect on the lessons learned thus far and the challenges ahead. Participants shared their experiences and thoughts relevant to best practices. As companies and ECHA are preparing for REACH evaluation, authorization and restriction, this seminar also explored ECHA's and industry's expectations. The use of science in this process was discussed as a key issue.
Topics to be covered: Cost Effective Consortium Management, The Next Phases of REACH, and Use of Science by ECHA
January 14, 2011, 10:00 - 14:30 hours
hosted by Hunton & Williams
1. Introduction — Lucas Bergkamp and Mike Penman
2. Cost Effective Management of REACH Registration and Consortia
- How to maintain REACH compliancy: Harrie Camps, EHSS-Corporate Control
- REACH — Legal state of play: Lucas Bergkamp, Hunton & Williams
- Efficient and Effective Consortium Management: Mike Penman, Penman Consulting, and Cristina Arregui, IFRA, followed by roundtable discussions
- How can companies handle multiple substance registrations, participation in multiple SIEFs and consortia, complex supply chains, and communications with customers: Leendert van Dijk, Eastman
- View from the outside - the expectations and contributions of non-EU manufacturers: DaeYoung Park, Young & Global Partners
3. Next Phases of REACH — What to expect from the ECHA after registration, and how to prepare
4. Use of Science by ECHA